News
08/15/2022
ivWatch Extends Its Global Reach Signing Three New Distribution Partners
Newport News, VA, ivWatch, LLC, an innovative IV safety company working to eliminate harm caused by infiltration and extravasation events, announced three new strategic distribution partnerships internationally. Bameco in Austria, Warba Medical Supplies in Kuwait, and Mustafa Sultan Science & Industry Co, LLC in Oman have each signed exclusive agreements to promote, sell, and support …
08/15/2022
Registration Now Open for Catalyst Life Sciences Conference
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), announced that registration is open for the Catalyst Life Sciences Conference. The event will be held October 6-7, 2022 at the Omni Hotel in Richmond, Virginia. This conference is designed for scientists, engineers, entrepreneurs, incubators and biohubs, life science companies, technology transfer …
08/13/2022
Kaléo launches government biz unit
Richmond pharma company also hires chief commercial officer. Richmond-based Kaléo on Thursday announced the formation of a new government business unit to focus on domestic and international procurement of the company’s system to reverse the effect of weaponized opioids as well as to provide access to it for military and civilian stockpiles. Kaléo’s Rapid …
08/10/2022
HemoShear Develops New Human Tissue-Based Model of Rare Liver Disease Under Research Collaboration with Takeda
Charlottesville, VA – HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has received a milestone payment under its October 2020 research collaboration and service agreement with Takeda. The milestone acknowledges development of a human tissue-based model of an undisclosed rare liver disease using the company’s REVEAL-Tx™ platform. REVEAL-Tx™ combines physiological and computational models of …
08/09/2022
The trust-builder: a cancer center director’s try-it-all strategy for breaking the barriers between research and Black patients
RICHMOND, Va. — The residents agreed: Nobody like Robert Winn — director of the Virginia Commonwealth University Massey Cancer Center — had ever visited the neighborhood before. This development on the outskirts of Richmond, more parking spots and asphalt than trees and lawn, was “the hood,” after all, they said. “This neighborhood — it’s been …
08/03/2022
Kaléo Enters Into Licensing Agreement With Valeo Pharma For The Canadian Rights to ALLERJECT®(epinephrine injection, USP)
Richmond, Va – Kaléo, a privately held U.S. pharmaceutical company, today announced that it has entered into a ten-year License, Supply, and Commercialization agreement with Valeo Pharma, a Canadian pharmaceutical company, for the Canadian rights to ALLERJECT® (epinephrine injection, USP) for the treatment of severe allergic reactions. “Patients with life threatening allergies across Canada deserve access to this …
07/28/2022
Virginia Bio and Virginia Bio Connect honored as “Top Employers for Interns” in Virginia!
RICHMOND – The Virginia Talent + Opportunity Partnership (V-TOP), in collaboration with the State Council of Higher Education for Virginia (SCHEV) and the Virginia Chamber of Commerce, recognized 32 recipients of the inaugural 2022 Top Virginia Employers for Interns Awards today. The virtual recognition event included video remarks from SCHEV Director, Peter Blake, Virginia Chamber …